Carregant...
Diabetes mellitus secondary to treatment with immune checkpoint inhibitors
Cancer immunotherapy has been one of the highlights in the advancement of cancer care. Certain immune checkpoint inhibitors bind to PD-1 on T cells and mediate an antitumour immune response. Given that immune checkpoint inhibitors are becoming part of standard care, a new class of adverse events—imm...
Guardat en:
| Publicat a: | Curr Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Multimed Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6380640/ https://ncbi.nlm.nih.gov/pubmed/30853817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4151 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|